Literature DB >> 17287212

The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.

Catherine E Gleason1, Danhong Lu, Lee A Witters, Christopher B Newgard, Morris J Birnbaum.   

Abstract

The AMP-activated protein kinase (AMPK) is a central regulator of the energy status of the cell, based on its unique ability to respond directly to fluctuations in the ratio of AMP:ATP. Because glucose and amino acids stimulate insulin release from pancreatic beta-cells by the regulation of metabolic intermediates, AMPK represents an attractive candidate for control of beta-cell function. Here, we show that inhibition of AMPK in beta-cells by high glucose inversely correlates with activation of the mammalian Target of Rapamycin (mTOR) pathway, another cellular sensor for nutritional conditions. Forced activation of AMPK by AICAR, phenformin, or oligomycin significantly blocked phosphorylation of p70S6K, a downstream target of mTOR, in response to the combination of glucose and amino acids. Amino acids also suppressed the activity of AMPK, and this at a minimum required the presence of leucine and glutamine. It is unlikely that the ability of AMPK to sense both glucose and amino acids plays a role in regulation of insulin secretion, as inhibition of AMPK by amino acids did not influence insulin secretion. Moreover, activation of AMPK by AICAR or phenformin did not antagonize glucose-stimulated insulin secretion, and insulin secretion was also unaffected in response to suppression of AMPK activity by expression of a dominant negative AMPK construct (K45R). Taken together, these results suggest that the inhibition of AMPK activity by glucose and amino acids might be an important component of the mechanism for nutrient-stimulated mTOR activity but not insulin secretion in the beta-cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287212     DOI: 10.1074/jbc.M610631200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  LKB1 signaling in advancing cell differentiation.

Authors:  Lina Udd; Tomi P Mäkelä
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

Review 2.  Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?

Authors:  Asish K Saha; X Julia Xu; Thomas W Balon; Amanda Brandon; Edward W Kraegen; Neil B Ruderman
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 3.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

4.  Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic α2A receptor through the mTOR (mammalian target of rapamycin) pathway: implication in new-onset diabetes in renal transplantation.

Authors:  Jun Yang; Michael Dolinger; Gabrielle Ritaccio; Joseph Mazurkiewicz; David Conti; Xinjun Zhu; Yunfei Huang
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 5.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

6.  SAD-A and AMPK kinases: the "yin and yang" regulators of mTORC1 signaling in pancreatic β cells.

Authors:  Jia Nie; Xiao Han; Yuguang Shi
Journal:  Cell Cycle       Date:  2013-09-18       Impact factor: 4.534

7.  AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut.

Authors:  Michelle L Bland; Robert J Lee; Julie M Magallanes; J Kevin Foskett; Morris J Birnbaum
Journal:  Dev Biol       Date:  2010-05-15       Impact factor: 3.582

Review 8.  The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.

Authors:  Yiwei Li; Vay Liang W Go; Fazlul H Sarkar
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

9.  Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism.

Authors:  Sarah M Ronnebaum; Jamie W Joseph; Olga Ilkayeva; Shawn C Burgess; Danhong Lu; Thomas C Becker; A Dean Sherry; Christopher B Newgard
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

10.  Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia.

Authors:  Craig Beall; Kaisa Piipari; Hind Al-Qassab; Mark A Smith; Nadeene Parker; David Carling; Benoit Viollet; Dominic J Withers; Michael L J Ashford
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.